6/7/2006 | BT | Market Commentary: Antigenics up 11% on data; Discovery Labs dives 19%; Incyte up; VaxGen slides
|
6/6/2006 | BT | Market Commentary: Xenoport deal emerges; Human Genome up 4%; Anadys, Idenix drop on HGSI news; Onyx up
|
5/30/2006 | BKHY | Millipore acquisition financing to include $750 million term debt, $400 million bridge loan
|
5/17/2006 | BT | Galapagos, Upstate to market adenovirus products
|
5/16/2006 | BT | Crucell agreement gives Upstate use of PER.C6 cell line
|
4/26/2006 | BT | Market Commentary: Inspire trial launch brings buyers; Avigen players hopeful; Applera units mixed; LifeCell lifted 15%
|
4/25/2006 | CV | Market Commentary: Serologicals weakens on hedged basis; JetBlue, Level 3 gain on results; Dov falls on drug trial woes
|
4/25/2006 | BKBTHY | S&P puts Serologicals on positive watch, Millipore on negative watch
|
4/25/2006 | BT | Millipore to acquire Serologicals in all-cash deal worth $1.4 billion
|
4/25/2006 | BT | Market Commentary: Serologicals, Millipore both up; other services names dip; DOV, Discovery dive; Neurocrine off
|
4/25/2006 | BKBT | Millipore plans approximately $900 million of new debt for Serologicals purchase
|
4/21/2006 | BT | Serologicals subsidiary, Australian Stem Cell Centre sign agreement to commercialize stem cell products
|
3/27/2006 | BKBT | Serologicals seeks $50 million term loan A for Linco purchase
|
3/23/2006 | BT | Serologicals to acquire Linco for $74.8 million
|
3/16/2006 | BT | Serologicals subsidiary expands distribution agreement with Novo Nordisk
|
3/14/2006 | BT | Cytomyx sells subsidiary to Serologicals for $7 million
|
1/6/2006 | BT | Serologicals closes Toronto facility
|
11/29/2005 | BT | SeraCare acquires Celliance manufacturing, product assets
|
6/21/2005 | BT | Market Commentary: Critical Therapeutics zooms after financing round; Mylan launches bank facility; Eyetech seen higher
|
12/17/2004 | BKCV | S&P ups Serologicals view to positive
|
12/7/2004 | BK | Serologicals to repay $80 million term loan with common stock proceeds
|
10/14/2004 | BK | Market Commentary: Dresser-Rand cuts U.S. term loan pricing; Peabody, JW Aluminum break for trading
|
9/28/2004 | BKCV | Moody's rates Serologicals loans Ba3
|
9/22/2004 | BKCV | S&P rates Serologicals loan BB-
|
9/17/2004 | BK | Market Commentary: Aquila jumps on the break; DirecTV plans rate cut; Charter lower as COO leaves
|
9/17/2004 | BK | Serologicals to launch $110 million loan via J.P. Morgan
|
9/8/2004 | BKCV | Moody's may cut Serologicals
|
9/8/2004 | BKCV | S&P: Serologicals unaffected
|
9/7/2004 | BK | Serologicals $140 million credit facility to launch within the next two weeks
|
7/20/2004 | BKCV | Moody's: Serologicals positive
|
9/22/2003 | CV | Market Commentary: Motorola gains with stock on CEO departure; BioMarin steady after drug canceled
|
8/20/2003 | CV | Serologicals greenshoe exercised, raising convertibles to $130 million
|
8/18/2003 | CV | Market Commentary: Alkermes returns to convertibles market; InVision reslated deal sweetened once, then again
|
8/18/2003 | BKCV | S&P rates Serologicals convertible B-
|
8/15/2003 | CV | Market Commentary: Serologicals upsized, Apria prices but InVision reslated for Monday due to blackout
|
8/15/2003 | CV | New Issue: Serologicals sells upsized $110 million convertible to yield 4.75%, up 27.5%
|
8/14/2003 | CV | Market Commentary: Another big block of Tyco sold, stirring concern about liquidations among hedgies
|
8/13/2003 | CV | Serologicals $100 million convertible talked at 4.25-4.75%, up 25-30%
|
8/13/2003 | CV | Market Commentary: New deal train chugs slowly along with string of small deals; dividend risk still high profile
|
8/13/2003 | BK | Serologicals to pay down bank debt with $100 million convertibles offering
|
4/7/2003 | BK | Market Commentary: Tesoro upsizes term loan B by $50 million, decreases bond offering by $25 million
|
3/7/2003 | BK | Market Commentary: Goodyear $1.3 billion loan seen attracting asset-based lenders due to good collateral package
|
3/6/2003 | BK | Market Commentary: Adelphia bank debt heads north as investor comfort on co-borrower issues grows
|
3/6/2003 | HY | S&P cuts O'Sullivan
|
3/6/2003 | BK | S&P cuts O'Sullivan
|